Bifunctional B-cell Targeted Therapy in IgG4-related Disease A novel B-cell depletion trial, using obexelimab has shown efficacy and safety in patients with active IgG4-related disease. https://t.co/JTfOrOLrrY https://t.co/ANY2YL25jT